跳至主要内容
临床试验/NCT02666612
NCT02666612Unknown不适用

Measurement and Characterization of Circulating Endothelial Cells or Circulating Tumor Cells or Circulating DNA in Adult Patients With Metastatic Cancer

Gustave Roussy, Cancer Campus, Grand Paris2 个研究点 分布在 1 个国家目标入组 2,240 人开始时间: 2008年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
2,240
试验地点
2
主要终点
Measurement and characterization of CEC and CEP and circulaing DNA rate using flow cytometry

研究概览

简要总结

Monitoring of circulating endothelial cells (CEC and mature cells called progenitors called CEP) or circulating tumor cells (CTC) in adult patients with metastatic cancer, possibly treated with targeted therapy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with metastatic solid tumor
  • Age> 18 years
  • Signed consent

排除标准

  • Patients with diseases associated with vascular lesions known.
  • Patients protected by law, in accordance with Articles L1121-5 to L1121-8 of the Code of Public Health.
  • Mental pathology that can interfere with the proper conduct of the study.
  • Refusal of consent.

结局指标

主要结局

Measurement and characterization of CEC and CEP and circulaing DNA rate using flow cytometry

时间窗: up to 2 years

Measurement and characterization of initial CEC and CEP circulaing DNA and their evolution under treatment

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验